Abstract
This study aims to establish a primary rat hepatocyte culture model to evaluate dose-dependent hepatotoxic effects of drug carriers (lipopolymer nanoparticles; LPNs) temporal. Primary rat hepatocyte cell cultures were used to determine half-maximal Inhibition Concentrations (IC50) of the drug-carrier library. Drug-carrier library, at concentrations <50 μg/mL, is benign to primary rat hepatocytes as determined using albumin and urea secretions. Albumin, as a hepatic biomarker, exhibited a more sensitive and faster outcome, compared to urea, for the determination of the IC50 value of LPNs. Temporal measurements of hepatic biomarkers including urea and albumin, and rigorous physicochemical (hydrodynamic diameter, surface charge, etc.) characterization, should be combined to evaluate the hepatotoxicity of drug carrier libraries in screens.
Original language | English (US) |
---|---|
Article number | 102651 |
Journal | Nanomedicine: Nanotechnology, Biology, and Medicine |
Volume | 48 |
DOIs | |
State | Published - Feb 2023 |
Keywords
- Hepatotoxicity
- In vitro culture
- Lipopolymer nanoparticle (LPN)
- Nanotoxicity
- Primary rat hepatocyte
ASJC Scopus subject areas
- Bioengineering
- Medicine (miscellaneous)
- Molecular Medicine
- Biomedical Engineering
- General Materials Science
- Pharmaceutical Science
Fingerprint
Dive into the research topics of 'Evaluation of drug carrier hepatotoxicity using primary cell culture models'. Together they form a unique fingerprint.Press/Media
-
Findings on Drug Delivery Systems Reported by Investigators at Massachusetts General Hospital (Evaluation of Drug Carrier Hepatotoxicity Using Primary Cell Culture Models)
5/29/23
1 item of Media coverage
Press/Media: Press / Media